Evaluation of the ability of the C-reactive protein-to-albumin ratio to predict short-term mortality in patients with COVID-19

Serdar Özdemir 1 * , Abdullah Algin 1 2
More Detail
1 University of Health Sciences Turkey, Ümraniye Training and Research Hospital, Clinic of Emergency Medicine, İstanbul, Turkey
2 University of Health Sciences Turkey, Somalia Mogadishu Recep Tayyip Erdogan Faculty of Health Sciences, Mogadishu, Somalia
* Corresponding Author
J CLIN MED KAZ, Volume 18, Issue 6, pp. 35-39. https://doi.org/10.23950/jcmk/11324
OPEN ACCESS 1505 Views 860 Downloads
Download Full Text (PDF)

ABSTRACT

Objective
This study aimed to determine the ability of the C-reactive protein (CRP)-to-albumin ratio (CAR) to predict short-term mortality in patients with COVID-19.
Material and methods
This retrospective, observational, cohort study included patients with COVID-19. The patients’ demographics, clinical characteristics, CRP, albumin, CAR, blood urea nitrogen, creatinine, Troponin I and all-cause mortality within 30 days after admission were noted. The receiver operating characteristic curve analysis was performed, and odds ratios were calculated to determine the discriminative ability of the parameters.
Results
A total of 103 patients with a median of age of 57 (20-92) years were included in the study. The rate of 30-day mortality was 4.8% for the study cohort. According to the best Youden’s index, the cut-off value for CRP was determined as 7 (sensitivity: 80%, specificity: 78.6%), and the area under curve (AUC) value was 0.801 (95% confidence interval: 71.1-87.3). According to the best Youden’s index, the cut-off value for CAR was 0.18 (sensitivity: 80%, specificity: 78.6%), and the area under curve (AUC) value was 0.806 (95% confidence interval: 71.6-87.7). There was no statistically significant difference between the AUC values of CRP and CAR (DeLong equality test, p = 0.938). The odds ratios of CRP (>7 mg/L) and CAR (>0.18) for 30-day mortality were 14.667 (95% confidence interval: 1.555-138.299) and 13.818 (95% confidence interval: 1.468-130.076), respectively.
Conclusion
CAR was not useful in predicting 30-day mortality in patients with COVID-19. The calculation of CAR rather than CRP had no clinically significant contribution to the prediction of 30-day mortality in this patient group.
Keywords: COVID-19, SARS-Cov-2, blood tests, coronavirus, C-reactive proteins, albumin, laboratory

CITATION

Özdemir S, Algin A. Evaluation of the ability of the C-reactive protein-to-albumin ratio to predict short-term mortality in patients with COVID-19. J CLIN MED KAZ. 2021;18(6):35-9. https://doi.org/10.23950/jcmk/11324

REFERENCES

  • Eroglu SE, Aksel G, Altunok I, et al. Can Google® trends predict emergency department admissions in pandemic periods? Medicine Science. 2021;10(1):111-117. https://doi.org/10.5455/medscience.2020.08.162
  • Sert E, Mutlu H, Kokulu K, Sarıtaş A. Anxiety Levels and Associated Factors Among Emergency Department Personnel Fighting COVID-19. J Contemp Med. 2020; 10(4): 556-561. https://doi.org/10.16899/jcm.972664
  • Zhou B, Kojima S, Kawamoto A, et al. COVID-19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations. J Med Virol. 2021;93(5):2694-2704. https://doi.org/10.1002/jmv.26754.
  • Gallo Marin B, Aghagoli G, Lavine K, et al. Predictors of COVID-19 severity: A literature review. Rev Med Virol. 2021;31(1):1-10. https://doi.org/10.1002/rmv.2146.
  • Özdemir S, Eroğlu SE, Algın A, et al. Analysis of laboratory parameters in patients with COVID-19: Experiences from a pandemic hospital. Ann Clin Anal Med. 2021;12 (Supp 4):518-523. https://doi.org/10.4328/ACAM.20678
  • Aksel G, İslam MM, Algın A, et al. Early predictors of mortality for moderate to severely ill patients with Covid-19. Am J Emerg Med. 2021;45:290-296. https://doi.org/10.1016/j.ajem.2020.08.076.
  • Seyit M, Avci E, Nar R, et al. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med. 2021;40:110-114. https://doi.org/10.1016/j.ajem.2020.11.058
  • Avramovski P, Avramovska M, Sotiroski K, Sikole A. Acute-phase proteins as promoters of abdominal aortic calcification in chronic dialysis patients. Saudi J Kidney Dis Transpl. 2019;30(2):376-386. https://doi.org/10.4103/1319-2442.256845.
  • Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29-36. https://doi.org/10.1148/radiology.143.1.7063747.
  • Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148(3):839-43. https://doi.org/10.1148/radiology.148.3.6878708.
  • Deeks JJ. Systematic reviews of evaluations of diagnostic and screening tests. Egger M Davey Smith G Altman DG eds. Systematic reviews in health care: meta-analysis in context. Systematic reviews, 2nd ed 2001:248-282 BMJ Books London.
  • Price CP, Newall RG, Boyd JC. Use of protein: creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review. Clin Chem. 2005;51(9):1577-86. https://doi.org/10.1373/clinchem.2005.049742.
  • Fischer JE, Bachmann LM, Jaeschke R. A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med. 2003;29(7):1043-51. https://doi.org/10.1007/s00134-003-1761-8.
  • Özdemir S, Akça HŞ, Algın A, et al. Can C-reactive protein-to-albumin ratio be a predictor of short-term mortality in community-acquired pneumonia? Ann Clin Anal Med. 2021;12(9):1043-1048. https://doi.org/ 10.4328/ACAM.20576.
  • Acet H, Güzel T, Aslan B, et al. Predictive Value of C-Reactive Protein to Albumin Ratio in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention. Angiology. 2021;72(3):244-251. https://doi.org/10.1177/0003319720963697.
  • Karakoyun I, Colak A, Turken M, et al. Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients. Int Immunopharmacol. 2021;91:107285. https://doi.org/10.1016/j.intimp.2020.107285.
  • Güney BÇ, Taştan YÖ, Doğantekin B, et al. Predictive Value of CAR for In-Hospital Mortality in Patients with COVID-19 Pneumonia: A Retrospective Cohort Study. Arch Med Res. 2021;52(5):554-560. https://doi.org/10.1016/j.arcmed.2021.02.006.
  • El-Shabrawy M, Alsadik M, El-Shafei M, et al. Interleukin-6 and C-reactive protein/albumin ratio as predictors of COVID-19 severity and mortality. The Egyptian Journal of Bronchology. 2021;15(1). https://doi.org/10.1186/s43168-021-00054-1
  • Paliogiannis P, Zinellu A, Scano V, et al. Laboratory test alterations in patients with COVID-19 and non-COVID-19 interstitial pneumonia: a preliminary report. J Infect Dev Ctries. 2020;14(7):685-690. https://doi.org/10.3855/jidc.12879.